IBDEI01O ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3634,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,3635,0)
 ;;=E87.5^^33^263^14
 ;;^UTILITY(U,$J,358.3,3635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3635,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,3635,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,3635,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,3636,0)
 ;;=E87.6^^33^263^20
 ;;^UTILITY(U,$J,358.3,3636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3636,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,3636,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,3636,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,3637,0)
 ;;=E87.8^^33^263^8
 ;;^UTILITY(U,$J,358.3,3637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3637,1,3,0)
 ;;=3^Electrolyte & Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,3637,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,3637,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,3638,0)
 ;;=E26.81^^33^263^5
 ;;^UTILITY(U,$J,358.3,3638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3638,1,3,0)
 ;;=3^Bartter's Syndrome
 ;;^UTILITY(U,$J,358.3,3638,1,4,0)
 ;;=4^E26.81
 ;;^UTILITY(U,$J,358.3,3638,2)
 ;;=^329906
 ;;^UTILITY(U,$J,358.3,3639,0)
 ;;=E23.2^^33^263^7
 ;;^UTILITY(U,$J,358.3,3639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3639,1,3,0)
 ;;=3^Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,3639,1,4,0)
 ;;=4^E23.2
 ;;^UTILITY(U,$J,358.3,3639,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,3640,0)
 ;;=E83.41^^33^263^15
 ;;^UTILITY(U,$J,358.3,3640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3640,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,3640,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,3640,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,3641,0)
 ;;=E21.3^^33^263^17
 ;;^UTILITY(U,$J,358.3,3641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3641,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,3641,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,3641,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,3642,0)
 ;;=E83.42^^33^263^21
 ;;^UTILITY(U,$J,358.3,3642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3642,1,3,0)
 ;;=3^Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,3642,1,4,0)
 ;;=4^E83.42
 ;;^UTILITY(U,$J,358.3,3642,2)
 ;;=^5003003
 ;;^UTILITY(U,$J,358.3,3643,0)
 ;;=N25.1^^33^263^25
 ;;^UTILITY(U,$J,358.3,3643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3643,1,3,0)
 ;;=3^Nephrogenic Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,3643,1,4,0)
 ;;=4^N25.1
 ;;^UTILITY(U,$J,358.3,3643,2)
 ;;=^5015616
 ;;^UTILITY(U,$J,358.3,3644,0)
 ;;=E27.49^^33^263^2
 ;;^UTILITY(U,$J,358.3,3644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3644,1,3,0)
 ;;=3^Adrenocortical Insufficiency,Other
 ;;^UTILITY(U,$J,358.3,3644,1,4,0)
 ;;=4^E27.49
 ;;^UTILITY(U,$J,358.3,3644,2)
 ;;=^5002743
 ;;^UTILITY(U,$J,358.3,3645,0)
 ;;=E72.09^^33^263^4
 ;;^UTILITY(U,$J,358.3,3645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3645,1,3,0)
 ;;=3^Amino-Acid Transport Disorders,Other
 ;;^UTILITY(U,$J,358.3,3645,1,4,0)
 ;;=4^E72.09
 ;;^UTILITY(U,$J,358.3,3645,2)
 ;;=^5002895
 ;;^UTILITY(U,$J,358.3,3646,0)
 ;;=N25.89^^33^263^23
 ;;^UTILITY(U,$J,358.3,3646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3646,1,3,0)
 ;;=3^Impaired Renal Tubular Function Disorders,Other
 ;;^UTILITY(U,$J,358.3,3646,1,4,0)
 ;;=4^N25.89
 ;;^UTILITY(U,$J,358.3,3646,2)
 ;;=^5015618
 ;;^UTILITY(U,$J,358.3,3647,0)
 ;;=E26.89^^33^263^12
 ;;^UTILITY(U,$J,358.3,3647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3647,1,3,0)
 ;;=3^Hyperaldosteronism,Other
 ;;^UTILITY(U,$J,358.3,3647,1,4,0)
 ;;=4^E26.89
 ;;^UTILITY(U,$J,358.3,3647,2)
 ;;=^5002737
 ;;^UTILITY(U,$J,358.3,3648,0)
 ;;=N25.81^^33^263^29
 ;;^UTILITY(U,$J,358.3,3648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3648,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,3648,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,3648,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,3649,0)
 ;;=E22.2^^33^263^28
 ;;^UTILITY(U,$J,358.3,3649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3649,1,3,0)
 ;;=3^SIADH
 ;;^UTILITY(U,$J,358.3,3649,1,4,0)
 ;;=4^E22.2
 ;;^UTILITY(U,$J,358.3,3649,2)
 ;;=^5002718
 ;;^UTILITY(U,$J,358.3,3650,0)
 ;;=E87.79^^33^263^10
 ;;^UTILITY(U,$J,358.3,3650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3650,1,3,0)
 ;;=3^Fluid Overload,Other
 ;;^UTILITY(U,$J,358.3,3650,1,4,0)
 ;;=4^E87.79
 ;;^UTILITY(U,$J,358.3,3650,2)
 ;;=^5003025
 ;;^UTILITY(U,$J,358.3,3651,0)
 ;;=E21.0^^33^263^27
 ;;^UTILITY(U,$J,358.3,3651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3651,1,3,0)
 ;;=3^Primary Hyperparathyroidism
 ;;^UTILITY(U,$J,358.3,3651,1,4,0)
 ;;=4^E21.0
 ;;^UTILITY(U,$J,358.3,3651,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,3652,0)
 ;;=E87.71^^33^263^30
 ;;^UTILITY(U,$J,358.3,3652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3652,1,3,0)
 ;;=3^Transfusion Associated Circulatory Overload
 ;;^UTILITY(U,$J,358.3,3652,1,4,0)
 ;;=4^E87.71
 ;;^UTILITY(U,$J,358.3,3652,2)
 ;;=^5003024
 ;;^UTILITY(U,$J,358.3,3653,0)
 ;;=D63.1^^33^264^1
 ;;^UTILITY(U,$J,358.3,3653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3653,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,3653,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,3653,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,3654,0)
 ;;=I12.0^^33^264^9
 ;;^UTILITY(U,$J,358.3,3654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3654,1,3,0)
 ;;=3^HTN w/ CKD w/ Stage 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,3654,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,3654,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,3655,0)
 ;;=I95.1^^33^264^10
 ;;^UTILITY(U,$J,358.3,3655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3655,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,3655,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,3655,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,3656,0)
 ;;=I95.89^^33^264^11
 ;;^UTILITY(U,$J,358.3,3656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3656,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,3656,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,3656,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,3657,0)
 ;;=N17.9^^33^264^12
 ;;^UTILITY(U,$J,358.3,3657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3657,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,3657,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,3657,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,3658,0)
 ;;=N18.5^^33^264^3
 ;;^UTILITY(U,$J,358.3,3658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3658,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,3658,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,3658,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,3659,0)
 ;;=N18.9^^33^264^4
 ;;^UTILITY(U,$J,358.3,3659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3659,1,3,0)
 ;;=3^Chronic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3659,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,3659,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,3660,0)
 ;;=N39.0^^33^264^14
 ;;^UTILITY(U,$J,358.3,3660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3660,1,3,0)
 ;;=3^Urinary Tract Infection,Unspec Site
 ;;^UTILITY(U,$J,358.3,3660,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,3660,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,3661,0)
 ;;=R31.9^^33^264^8
 ;;^UTILITY(U,$J,358.3,3661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3661,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,3661,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,3661,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,3662,0)
 ;;=R31.0^^33^264^7
 ;;^UTILITY(U,$J,358.3,3662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3662,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,3662,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,3662,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,3663,0)
 ;;=R60.9^^33^264^6
 ;;^UTILITY(U,$J,358.3,3663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3663,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,3663,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,3663,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,3664,0)
 ;;=R07.89^^33^264^2
 ;;^UTILITY(U,$J,358.3,3664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3664,1,3,0)
 ;;=3^Chest Pain,Other
 ;;^UTILITY(U,$J,358.3,3664,1,4,0)
 ;;=4^R07.89
 ;;^UTILITY(U,$J,358.3,3664,2)
 ;;=^5019200
 ;;^UTILITY(U,$J,358.3,3665,0)
 ;;=Z99.2^^33^264^5
 ;;^UTILITY(U,$J,358.3,3665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3665,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,3665,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,3665,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,3666,0)
 ;;=Z91.15^^33^264^13
 ;;^UTILITY(U,$J,358.3,3666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3666,1,3,0)
 ;;=3^Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,3666,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,3666,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,3667,0)
 ;;=N18.6^^33^265^4
 ;;^UTILITY(U,$J,358.3,3667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3667,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,3667,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,3667,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,3668,0)
 ;;=N12.^^33^265^19
 ;;^UTILITY(U,$J,358.3,3668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3668,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Not Acute or Chronic
 ;;^UTILITY(U,$J,358.3,3668,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,3668,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,3669,0)
 ;;=N20.0^^33^265^2
 ;;^UTILITY(U,$J,358.3,3669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3669,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,3669,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,3669,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,3670,0)
 ;;=R30.0^^33^265^3
 ;;^UTILITY(U,$J,358.3,3670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3670,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,3670,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,3670,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,3671,0)
 ;;=R80.3^^33^265^1
 ;;^UTILITY(U,$J,358.3,3671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3671,1,3,0)
 ;;=3^Bence Jones Proteinuria
 ;;^UTILITY(U,$J,358.3,3671,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,3671,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,3672,0)
 ;;=N40.1^^33^265^5
 ;;^UTILITY(U,$J,358.3,3672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3672,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,3672,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,3672,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,3673,0)
 ;;=R31.0^^33^265^6
 ;;^UTILITY(U,$J,358.3,3673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3673,1,3,0)
 ;;=3^Gross Hematuria
 ;;^UTILITY(U,$J,358.3,3673,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,3673,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,3674,0)
 ;;=R31.9^^33^265^7
 ;;^UTILITY(U,$J,358.3,3674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3674,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,3674,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,3674,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,3675,0)
 ;;=R80.0^^33^265^9
 ;;^UTILITY(U,$J,358.3,3675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3675,1,3,0)
 ;;=3^Isolated Proteinuria
 ;;^UTILITY(U,$J,358.3,3675,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,3675,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,3676,0)
 ;;=R39.14^^33^265^8
 ;;^UTILITY(U,$J,358.3,3676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3676,1,3,0)
 ;;=3^Incomplete Bladder Emptying
 ;;^UTILITY(U,$J,358.3,3676,1,4,0)
 ;;=4^R39.14
 ;;^UTILITY(U,$J,358.3,3676,2)
 ;;=^5019344
 ;;^UTILITY(U,$J,358.3,3677,0)
 ;;=R35.1^^33^265^12
 ;;^UTILITY(U,$J,358.3,3677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3677,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,3677,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,3677,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,3678,0)
 ;;=R80.1^^33^265^14
 ;;^UTILITY(U,$J,358.3,3678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3678,1,3,0)
 ;;=3^Persistent Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,3678,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,3678,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,3679,0)
 ;;=R35.8^^33^265^15
 ;;^UTILITY(U,$J,358.3,3679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3679,1,3,0)
 ;;=3^Polyuria,Other
 ;;^UTILITY(U,$J,358.3,3679,1,4,0)
 ;;=4^R35.8
 ;;^UTILITY(U,$J,358.3,3679,2)
 ;;=^5019336
 ;;^UTILITY(U,$J,358.3,3680,0)
 ;;=R80.2^^33^265^13
 ;;^UTILITY(U,$J,358.3,3680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3680,1,3,0)
 ;;=3^Orthostatic Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,3680,1,4,0)
 ;;=4^R80.2
 ;;^UTILITY(U,$J,358.3,3680,2)
 ;;=^5019597
 ;;^UTILITY(U,$J,358.3,3681,0)
 ;;=R80.8^^33^265^16
 ;;^UTILITY(U,$J,358.3,3681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3681,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,3681,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,3681,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,3682,0)
 ;;=R39.16^^33^265^18
 ;;^UTILITY(U,$J,358.3,3682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3682,1,3,0)
 ;;=3^Straining on Urination
 ;;^UTILITY(U,$J,358.3,3682,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,3682,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,3683,0)
 ;;=R35.0^^33^265^20
 ;;^UTILITY(U,$J,358.3,3683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3683,1,3,0)
 ;;=3^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,3683,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,3683,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,3684,0)
 ;;=R39.11^^33^265^21
 ;;^UTILITY(U,$J,358.3,3684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3684,1,3,0)
 ;;=3^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,3684,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,3684,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,3685,0)
 ;;=N39.41^^33^265^25
 ;;^UTILITY(U,$J,358.3,3685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3685,1,3,0)
 ;;=3^Urinary Urge Incontinence
 ;;^UTILITY(U,$J,358.3,3685,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,3685,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,3686,0)
 ;;=N13.8^^33^265^22
 ;;^UTILITY(U,$J,358.3,3686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3686,1,3,0)
 ;;=3^Urinary Obstruction
 ;;^UTILITY(U,$J,358.3,3686,1,4,0)
 ;;=4^N13.8
 ;;^UTILITY(U,$J,358.3,3686,2)
 ;;=^5015588
 ;;^UTILITY(U,$J,358.3,3687,0)
 ;;=R33.8^^33^265^23
 ;;^UTILITY(U,$J,358.3,3687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3687,1,3,0)
 ;;=3^Urinary Retention,Other
 ;;^UTILITY(U,$J,358.3,3687,1,4,0)
 ;;=4^R33.8
 ;;^UTILITY(U,$J,358.3,3687,2)
 ;;=^5019331
 ;;^UTILITY(U,$J,358.3,3688,0)
 ;;=R39.15^^33^265^26
 ;;^UTILITY(U,$J,358.3,3688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3688,1,3,0)
 ;;=3^Urinary Urgency
 ;;^UTILITY(U,$J,358.3,3688,1,4,0)
 ;;=4^R39.15
 ;;^UTILITY(U,$J,358.3,3688,2)
 ;;=^5019345
 ;;^UTILITY(U,$J,358.3,3689,0)
 ;;=R39.12^^33^265^27
 ;;^UTILITY(U,$J,358.3,3689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3689,1,3,0)
 ;;=3^Weak Urinary Stream
 ;;^UTILITY(U,$J,358.3,3689,1,4,0)
 ;;=4^R39.12
 ;;^UTILITY(U,$J,358.3,3689,2)
 ;;=^5019342
 ;;^UTILITY(U,$J,358.3,3690,0)
 ;;=R80.9^^33^265^17
 ;;^UTILITY(U,$J,358.3,3690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3690,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,3690,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,3690,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,3691,0)
 ;;=R31.21^^33^265^10
 ;;^UTILITY(U,$J,358.3,3691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3691,1,3,0)
 ;;=3^Microscopic Hematuria,Asymptomatic
 ;;^UTILITY(U,$J,358.3,3691,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,3691,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,3692,0)
 ;;=R31.29^^33^265^11
 ;;^UTILITY(U,$J,358.3,3692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3692,1,3,0)
 ;;=3^Microscopic Hematuria,Other
 ;;^UTILITY(U,$J,358.3,3692,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,3692,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,3693,0)
 ;;=R33.9^^33^265^24
 ;;^UTILITY(U,$J,358.3,3693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3693,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,3693,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,3693,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,3694,0)
 ;;=D51.8^^33^266^2
 ;;^UTILITY(U,$J,358.3,3694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3694,1,3,0)
 ;;=3^Anemia,Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,3694,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,3694,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,3695,0)
 ;;=D52.9^^33^266^1
 ;;^UTILITY(U,$J,358.3,3695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3695,1,3,0)
 ;;=3^Anemia,Folate Deficiency
 ;;^UTILITY(U,$J,358.3,3695,1,4,0)
 ;;=4^D52.9
 ;;^UTILITY(U,$J,358.3,3695,2)
 ;;=^5002293
 ;;^UTILITY(U,$J,358.3,3696,0)
 ;;=I10.^^33^267^12
 ;;^UTILITY(U,$J,358.3,3696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3696,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,3696,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,3696,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,3697,0)
 ;;=I15.0^^33^267^13
 ;;^UTILITY(U,$J,358.3,3697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3697,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,3697,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,3697,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,3698,0)
 ;;=I13.11^^33^267^8
 ;;^UTILITY(U,$J,358.3,3698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3698,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 5 Chr Kidney/ESRD
 ;;^UTILITY(U,$J,358.3,3698,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,3698,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,3699,0)
 ;;=I13.2^^33^267^7
 ;;^UTILITY(U,$J,358.3,3699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3699,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 5 Chr Kidney/ESRD
 ;;^UTILITY(U,$J,358.3,3699,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,3699,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,3700,0)
 ;;=I70.1^^33^267^3
 ;;^UTILITY(U,$J,358.3,3700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3700,1,3,0)
 ;;=3^Atherosclerosis of Renal Artery
 ;;^UTILITY(U,$J,358.3,3700,1,4,0)
 ;;=4^I70.1
 ;;^UTILITY(U,$J,358.3,3700,2)
 ;;=^269760
 ;;^UTILITY(U,$J,358.3,3701,0)
 ;;=I77.3^^33^267^2
 ;;^UTILITY(U,$J,358.3,3701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3701,1,3,0)
 ;;=3^Arterial Fibromuscular Dysplasia
 ;;^UTILITY(U,$J,358.3,3701,1,4,0)
 ;;=4^I77.3
 ;;^UTILITY(U,$J,358.3,3701,2)
 ;;=^5007812
 ;;^UTILITY(U,$J,358.3,3702,0)
 ;;=E26.02^^33^267^5
 ;;^UTILITY(U,$J,358.3,3702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3702,1,3,0)
 ;;=3^Glucocorticoid-Remediable Aldosteronism
 ;;^UTILITY(U,$J,358.3,3702,1,4,0)
 ;;=4^E26.02
 ;;^UTILITY(U,$J,358.3,3702,2)
 ;;=^329904
 ;;^UTILITY(U,$J,358.3,3703,0)
 ;;=I12.9^^33^267^14
 ;;^UTILITY(U,$J,358.3,3703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3703,1,3,0)
 ;;=3^Hypertensive CKD Stage 1-4
 ;;^UTILITY(U,$J,358.3,3703,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,3703,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,3704,0)
 ;;=I12.0^^33^267^15
 ;;^UTILITY(U,$J,358.3,3704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3704,1,3,0)
 ;;=3^Hypertensive CKD Stage 5 or ESRD
 ;;^UTILITY(U,$J,358.3,3704,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,3704,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,3705,0)
 ;;=I13.0^^33^267^6
 ;;^UTILITY(U,$J,358.3,3705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3705,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 1-4 Chr Kidney
 ;;^UTILITY(U,$J,358.3,3705,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,3705,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,3706,0)
 ;;=I13.10^^33^267^9
 ;;^UTILITY(U,$J,358.3,3706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3706,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 1-4 Chr Kidney
